| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider activity in NKTR over the last quarter tilts toward selling: insiders offloaded a net 604 shares worth roughly $43K.
Classified under Biotechnology (Health Care sector), NKTR's insider flows are most useful compared with peers in the same group.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 54.6K | $3.93M | - | |
| Other | 21.6K | $1.17M | - | |
| Dir | 19.0K | - | - | |
| Dir | 16.4K | - | - | |
| Other | 9.6K | $688.8K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug 18, 2026 | Zalevsky Jonathan63 | Chief R&D Officer | Sell | 186 | $71.98 | $13,388.28 | -1.9% | - | - | |
| Aug 18, 2026 | Robin Howard W58 | President &CEO | Sell | 418 | $71.98 | $30,087.64 | -0.8% | - | - | |
| Jun 30, 2026 | Zalevsky Jonathan63 | Chief R&D Officer | Sell | 5,681 | $70.00 | $397,670.00 | -36.8% | -13.5% | - | |
| Jun 17, 2026 | Robin Howard W58 | President &CEO | Sell | 20,000 | $60.75 | $1,215,055.78 | -26.7% | +9.4% | - | |
| Jun 15, 2026 | Zalevsky Jonathan63 | Chief R&D Officer | Sell | 5,538 | $60.71 | $336,211.98 | -26.4% | +12.0% | - | |
| May 19, 2026 | Zalevsky Jonathan63 | Chief R&D Officer | Sell | 199 | $65.51 | $13,036.49 | -0.9% | +7.5% | - | |
| May 19, 2026 | Robin Howard W58 | President &CEO | Sell | 444 | $65.51 | $29,086.44 | -0.6% | +7.5% | - | |
| Feb 18, 2026 | Robin Howard W58 | President &CEO | Sell | 423 | $73.00 | $30,879.00 | -0.6% | -7.7% | - | |
| Feb 18, 2026 | Zalevsky Jonathan63 | Chief R&D Officer | Sell | 180 | $73.00 | $13,140.00 | -0.8% | -7.7% | - | |
| Jan 20, 2026 | Zalevsky Jonathan63 | Chief R&D Officer | Sell | 3,867 | $35.67 | $137,935.89 | -15.3% | +177.0% | - |